Researchers have identified specific small non-coding RNA molecules, known as piRNAs, that may serve as potent biomarkers for predicting all-cause mortality. This breakthrough suggests that a single blood test could eventually quantify biological aging and help clinicians identify high-risk patients long before clinical symptoms of age-related decline emerge. More on the research.

A new study analyzed piRNA — first discovered in 2006 — as a strong predictor of short-term survival in older patients. It could one day be a simple blood test.